Lilly Files for European Approval of ALIMTA(R) (pemetrexed for injection) for First-Line Treatment of Non-Small Cell … (PR Newswire via Yahoo! Finance)

Eli Lilly and Company today announced that it has submitted an application with the European Medicines Agency for centralised review of ALIMTA® , in combination with cisplatin, for the first-line treatment of advanced non-small cell lung cancer .

More: continued here




   Posted in mesothelioma    

Subscribe RSS 2.0 feed. Leave a response, or Trackback from your own site.






Leave a Reply